Drug Profile
Research programme: cannabinoid based therapeutics - Lara Pharmaceuticals
Alternative Names: LP-306Latest Information Update: 28 May 2018
Price :
$50
*
At a glance
- Originator LaraPharm
- Class Cannabinoids; Non-opioid analgesics; Small molecules
- Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 May 2018 No recent reports of development identified for research development in Pain in Israel (Inhalation, Inhalant)
- 01 Apr 2014 Early research in Pain in Israel (Inhalation)